Form DEFA14A AVANOS MEDICAL, INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange

Act of 1934 (Amendment No. )

 

þ Filed by the Registrant

¨ Filed by a Party other than the Registrant

 

Check the appropriate box:
¨	Preliminary Proxy Statement
¨	CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
¨	Definitive Proxy Statement
þ	Definitive Additional Materials
¨	Soliciting Material Under § 240.14a-12

 

Avanos Medical, Inc.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):
þ	No fee required.
¨	Fee paid previously with preliminary materials.
¨	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

Important Information

 

On April 14, 2026, Avanos Medical, Inc. announced that it has postponed its 2026 Annual Meeting of Stockholders, which was previously scheduled for April 21, 2026, in light of the announcement of its pending merger.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• American Industrial Partners acquires Avanos Medical for $1.27B
• SAGA Metals Mobilizes Camp Construction Ahead of Drilling at Wolverine Heavy Rare Earth Element Project in Labrador
• ASSA ABLOY to acquire Gunnebo Entrance Control